Jardiance Approved for Heart Failure with Reduced Ejection Fraction
The approval was based on data from the phase 3 EMPEROR-Reduced trial.
Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approval was based on data from the phase 3 EMPEROR-Reduced trial.
The FDA has approved Jemperli (dostarlimab-gxly) for adults with mismatch repair-deficient (dMMR) recurrent or advanced solid tumors.
The FDA will review the sBLAs for pembrolizumab (Keytruda) for renal cell carcinoma and advanced endometrial carcinoma.
/PRNewswire/ -- Today, Events DC, the official convention and sports authority for the District of Columbia, and MAVEN Security Technologies announced the...
/PRNewswire/ -- Today, Events DC, the official convention and sports authority for the District of Columbia, and MAVEN Security Technologies announced the...